SCHEMBL7833984

SCHEMBL7833984

Cc1ccc2c(-c3ccccc3)cccc2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.57
PSMB5 P28074 1/20 0.50
CYP2A6 P11509 3/20 0.48
TDP1 Q9NUW8 1/20 0.48
KDM4E B2RXH2 4/20 0.47
ALDH1A1 P00352 4/20 0.47
MAPT P10636 3/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
HPGD P15428 1/20 0.47
MPI P34949 1/20 0.47
MAOB P27338 3/20 0.46
MAOA P21397 1/20 0.45
TLR8 Q9NR97 1/20 0.45
TNF P01375 1/20 0.44
LMNA P02545 2/20 0.44
RECQL P46063 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
HSD17B1 P14061 1/20 0.44
HSD17B2 P37059 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL27919176 0.98 CYP1A2 (0.55) CYP1A2PSMB5CYP2A6TDP1KDM4E
SCHEMBL27430792 0.90 CYP1A2 (0.59) CYP1A2CYP2A6TDP1KDM4EALDH1A1
SCHEMBL29506869 0.86 CYP1A2 (0.68) CYP1A2CYP2A6TDP1KDM4EALDH1A1
SCHEMBL7824111 0.85 CYP2A6 (0.57) CYP1A2PSMB5CYP2A6TDP1KDM4E
SCHEMBL26048387 0.84 CYP1A2 (0.41) CYP1A2PSMB5CYP2A6TDP1KDM4E
SCHEMBL14904215 0.84 CYP1A2 (0.52) CYP1A2CYP2A6TDP1KDM4EALDH1A1
SCHEMBL8590628 0.84 CYP1A2 (0.52) CYP1A2PSMB5CYP2A6TDP1KDM4E
SCHEMBL18561790 0.84 CYP1A2 (0.52) CYP1A2CYP2A6TDP1KDM4EALDH1A1
Ammonia Solution, Strong SCHEMBL27919231 0.83 CYP2A6 (0.55) CYP1A2PSMB5CYP2A6TDP1KDM4E
SCHEMBL13241132 0.81 MAOB (0.50) CYP1A2TDP1KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0676398-B1 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO CO (JP) 2001-10-24 EP disclosed
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 US disclosed
EP-1022274-A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use Sankyo Company Limited (JP) 2000-07-26 EP disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 US disclosed
US-5962470-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 1999-10-05 US disclosed
US-5886014-A TREATMENT AND/OR PROPHYLAXIS OF A VARIETY OF DISORDERS, INCLUDING HYPERLIPEMIA, HYPERGLYCEMIA, OBESITY, IMPAIRED GLUCOSE TOLERANCE (IGT), INSULIN RESISTANCE AND DIABETIC COMPLICATIONS SANKYO COMPANY, LIMITED (JP) 1999-03-23 US disclosed
US-5834501-A TREATING DIABETES OR HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1998-11-10 US disclosed
US-5739345-A HYPOGLYCEMIC AND ANTIDIABETIC AGENTS SANKYO COMPANY, LIMITED (JP) 1998-04-14 US disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 US disclosed
EP-0745600-A1 Benzimidazole derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-12-04 EP disclosed
EP-0676398-A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO COMPANY LIMITED (JP) 1995-10-11 EP disclosed